BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 17659189)

  • 21. Differential diagnosis of Parkinson's disease and the parkinsonism plus syndromes.
    Stacy M; Jankovic J
    Neurol Clin; 1992 May; 10(2):341-59. PubMed ID: 1584178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene.
    Soliveri P; Rossi G; Monza D; Tagliavini F; Piacentini S; Albanese A; Bugiani O; Girotti F
    Arch Neurol; 2003 Oct; 60(10):1454-6. PubMed ID: 14568818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression profiling of substantia nigra in Parkinson disease, progressive supranuclear palsy, and frontotemporal dementia with parkinsonism.
    Hauser MA; Li YJ; Xu H; Noureddine MA; Shao YS; Gullans SR; Scherzer CR; Jensen RV; McLaurin AC; Gibson JR; Scott BL; Jewett RM; Stenger JE; Schmechel DE; Hulette CM; Vance JM
    Arch Neurol; 2005 Jun; 62(6):917-21. PubMed ID: 15956162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study.
    Aarsland D; Perry R; Brown A; Larsen JP; Ballard C
    Ann Neurol; 2005 Nov; 58(5):773-6. PubMed ID: 16240351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease.
    Rizzo G; Martinelli P; Manners D; Scaglione C; Tonon C; Cortelli P; Malucelli E; Capellari S; Testa C; Parchi P; Montagna P; Barbiroli B; Lodi R
    Brain; 2008 Oct; 131(Pt 10):2690-700. PubMed ID: 18819991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is 'early onset dementia'?
    Miyoshi K
    Psychogeriatrics; 2009 Jun; 9(2):67-72. PubMed ID: 19604328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent developments in the neuropathological diagnosis of Parkinson's disease and parkinsonism.
    Michotte A
    Acta Neurol Belg; 2003 Sep; 103(3):155-8. PubMed ID: 14626695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frontotemporal dementia--Part II. Differential diagnosis, genetics, molecular pathomechanism and pathology.
    Galariotis V; Bódi N; Janka Z; Kálmán J
    Ideggyogy Sz; 2005 Jul; 58(7-8):220-4. PubMed ID: 16173270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic criteria of parkinsonian syndromes].
    Tison F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S19-23. PubMed ID: 12773884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rivastigmine in Parkinson's disease dementia.
    Chitnis S; Rao J
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):941-55. PubMed ID: 19619073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Alzheimer dementias.
    Nestor P; Hodges J
    Semin Neurol; 2000; 20(4):439-46. PubMed ID: 11149699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical features of corticobasal degeneration].
    Farsang M; Takáts A; Szirmai I; Kovács T
    Ideggyogy Sz; 2005 Jan; 58(1-2):45-51. PubMed ID: 15884398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Argyrophilic grain disease clinically mimicking Parkinson's disease with dementia: report of an autopsy case].
    Uchikado H; Tsuchiya K; Tominaga I; Togo T; Oshima K; Akiyama H; Ikeda K; Oda T; Hirayasu Y
    No To Shinkei; 2004 Sep; 56(9):785-8. PubMed ID: 15552868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Frontotemporal dementia and frontotemporal degeneration--how to define?].
    Mori H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):872-4. PubMed ID: 15651318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A 64-year-old man with parkinsonism as an initial symptom followed by dementia associated with marked abnormal behaviours].
    Suzuki A; Ikebe S; Komatsuzaki Y; Takanashi M; Mori H; Hattori N; Mizuno Y
    No To Shinkei; 2001 Nov; 53(11):1075-87. PubMed ID: 11761920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in dementia research in Japan: non-Alzheimer-type degenerative dementias.
    Kosaka K; Iseki E
    Psychiatry Clin Neurosci; 1998 Aug; 52(4):367-73. PubMed ID: 9766683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological substrate of dementia in Parkinson's disease--its relation to DLB and DLBD.
    Jellinger KA
    Parkinsonism Relat Disord; 2006 Mar; 12(2):119-20. PubMed ID: 16337163
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of intellectual functions in patients with Parkinson's disease. Bibliographic review].
    Piccirilli M; Piccinin GL; Lamedica A
    Riv Patol Nerv Ment; 1981; 101(5):225-46. PubMed ID: 6172833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
    Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
    Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.